High nuclear protein kinase CβII expression is a marker of disease recurrence in oral squamous cell carcinoma

Anticancer Research

Volumn 32, Issue 9, 2012, Pages 3987-3991

  Chu, Pei Yi ^a   Hsu, Nicholas Chung Heng ^b   Lin, Shu Hui ^c,d   Hou, Ming Feng ^e,f   Yeh, Kun Tu ^c,e,g  

^a St Martin De Porres Hospital   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Molecular marker; Nuclear expression; Oral cancer; Protein kinase C II; Recurrence

Indexed keywords

PROTEIN KINASE C BETA;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MOUTH MUCOSA; MOUTH SQUAMOUS CELL CARCINOMA; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECURRENT CANCER; SCORING SYSTEM; TUMOR VOLUME;

CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; FEMALE; HUMANS; MALE; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PARAFFIN EMBEDDING; PROTEIN KINASE C; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84867000792     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Fedele S: Diagnostic aids in the screening of oral cancer. Head Neck Oncol 1 : 5, 2009.
2. Yang YH, Chen CH, Chang JS, Lin CC, Cheng TC and Shieh TY: Incidence rates of oral cancer and oral pre-cancerous lesions in a 6-year follow-up study of a Taiwanese aboriginal community. J Oral Pathol Med 34: 596-601, 2005.
3. Leite IC and Koifman S: Survival analysis in a sample of oral cancer patients at a reference hospital in Rio de Janeiro, Brazil. Oral Oncol 34: 347-352, 1998.
4. Lo WL, Kao SY, Chi LY, Wong YK and Chang RC: Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: Factors affecting survival. J Oral Maxillofac Surg 61: 751-758, 2003.
5. Martiny-Baron G and Fabbro D: Classical PKC isoforms in cancer. Pharmacol Res 55 : 477-486, 2007.
6. Griner EM and Kazanietz MG: Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 7: 281-294, 2007.
7. Gutcher I, Webb PR and Anderson NG: The isoform-specific regulation of apoptosis by protein kinase C. Cell Mol Life Sci 60: 1061-1070, 2003.
8. Koivunen J, Aaltonen V and Peltonen J: Protein kinase C (PKC) family in cancer progression. Cancer Lett 235: 1-10, 2006.
9. Nishizuka Y: Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9: 484-496, 1995.
10. Usha L, Sill MW, Darcy KM, Benbrook DM, Hurteau JA, Michelin DP, Mannel RS, Hanjani P, De Geest K and Godwin AK: A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies. Gynecol Oncol 121: 455-461, 2011.
11. Podar K, Raab MS, Chauhan D and Anderson KC: The therapeutic role of targeting protein kinase C in solid and hematologic malignancies. Expert Opin Investig Drugs 16: 1693-1707, 2007.
12. Fields AP and Murray NR: Protein kinase C isozymes as therapeutic targets for treatment of human cancers. Adv Enzyme Regul 48 : 166-178, 2008.
13. Gokmen-Polar Y, Mehta R, Tuzmen S, Mousses S, Thorat MA, Sanders KL, Turbin D, Leung S, Huntsman DG, Sledge GW, Jr. and Badve S: Differential subcellular expression of protein kinase C βII in breast cancer: correlation with breast cancer subtypes. Breast Cancer Res Treat 124: 327-335, 2010.
14. Gokmen-Polar Y, Murray NR, Velasco MA, Gatalica Z and Fields AP: Elevated protein kinase C βII is an early promotive event in colon carcinogenesis. Cancer Res 61: 1375-1381, 2001.
15. Yu W, Murray NR, Weems C, Chen L, Guo H, Ethridge R, Ceci JD, Evers BM, Thompson EA and Fields AP: Role of cyclooxygenase 2 in protein kinase C βII-mediated colon carcinogenesis. J Biol Chem 278: 11167-11174, 2003.
16. Davidson LA, Aymond CM, Jiang YH, Turner ND, Lupton JR and Chapkin RS: Non-invasive detection of fecal protein kinase C βII and ζ messenger RNA: putative biomarkers for colon cancer. Carcinogenesis 19 : 253-257, 1998.
17. Graff JR, McNulty AM, Hanna KR, Konicek BW, Lynch RL, Bailey SN, Banks C, Capen A, Goode R, Lewis JE, Sams L, Huss KL, Campbell RM, Iversen PW, Neubauer BL, Brown TJ, Musib L, Geeganage S and Thornton D: The protein kinase Cβ- selective inhibitor, enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts. Cancer Res 65: 7462-7469, 2005.
18. Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, Ray TS, Koval MA, Last KW, Norton A, Lister TA, Mesirov J, Neuberg DS, Lander ES, Aster JC and Golub TR: Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 8: 68-74, 2002.
19. Newton AC: Protein kinase C: Structural and spatial regulation by phosphorylation, co-factors, and macromolecular interactions. Chem Rev 101 : 2353-2364, 2001.
20. Martelli AM, Sang N, Borgatti P, Capitani S and Neri LM: Multiple biological responses activated by nuclear protein kinase C. J Cell Biochem 74 : 499-521, 1999.
21. Lee MJ, Hsu JD, Lin CL, Lin MH, Yuan SC and Wang CJ: Induction of epidermal proliferation and expressions of PKC and NF-κB by betel quid extracts in mouse: The role of lime-piper additives in betel quid. Chem Biol Interact 140: 35-48, 2002.
22. Newton PM and Ron D: Protein kinase C and alcohol addiction. Pharmacol Res 55: 570-577, 2007.
23. Chiang CT, Chang TK, Hwang YH, Su CC, Tsai KY, Yuan TH and Lian Ie B: A critical exploration of blood and environmental chromium concentration among oral cancer patients in an oral cancer-prevalent area of Taiwan. Environ Geochem Health 33: 469-476, 2011.
24. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM and Tsai CC: Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 24: 450-453, 1995.
25. Fields AP, Calcagno SR, Krishna M, Rak S, Leitges M and Murray NR: Protein kinase Cβ is an effective target for chemoprevention of colon cancer. Cancer Res 69: 1643-1650, 2009.
26. Robertson MJ, Kahl BS, Vose JM, de Vos S, Laughlin M, Flynn PJ, Rowland K, Cruz JC, Goldberg SL, Musib L, Darstein C, Enas N, Kutok JL, Aster JC, Neuberg D, Savage KJ, LaCasce A, Thornton D, Slapak CA and Shipp MA: Phase II study of enzastaurin, a protein kinase C β inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma. J Clin Oncol 25: 1741-1746, 2007.